HemoClear introduced in 1.30 minutes

About Us

Mission

HemoClear is a leading medical device manufacturing company that is dedicated to pursuing innovation in the development of practical and highly effective medical devices. Our mission is to offer new and reliable solutions for treating severe or life-threatening diseases.

Read more

Team

At HemoClear we work with the best and brightest people in their field in a diverse and inclusive organization where everybody contributes, irrespective of cultural, ethnic, or religious background, gender, sexual orientation, health, and age.

Read more

Vacancies

At our company, we firmly believe that a vibrant and inclusive company culture is the foundation for success. We strive to create an environment that not only values the expertise and skills of our employees but also encourages them to share their thoughts, feelings, and suggestions openly.

Read more

Boost Autologuous bloodtransfusion Options
object(WP_Post)#10463 (24) { ["ID"]=> int(767) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2019-12-20 10:57:20" ["post_date_gmt"]=> string(19) "2019-12-20 10:57:20" ["post_content"]=> string(532) "

HemoClear and Pennine Healthcare team up to develop and manufacture a complete ready-to-use HemoClear accessories kit.  The kit contains all material to recuperate red blood cells from patient shed blood, enabling autologous blood transfusion. In this cooperation Pennine Healthcare obtained the exclusive commercial HemoClear distribution rights for the United Kingdom and Ireland.

" ["post_title"]=> string(53) "HemoClear Is Proud To Partner With Pennine Healthcare" ["post_excerpt"]=> string(18) "Lorem ipsum etc..." ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(30) "pennine-healthcare-cooperation" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-06-29 10:00:29" ["post_modified_gmt"]=> string(19) "2023-06-29 10:00:29" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(33) "https://test.hemoclear.com/?p=767" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }
Boost Autologuous bloodtransfusion Options
object(WP_Post)#10459 (24) { ["ID"]=> int(5005) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-06-13 08:22:00" ["post_date_gmt"]=> string(19) "2023-06-13 08:22:00" ["post_content"]=> string(2508) "

Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs). 

Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs). 

Most blood recipients in sub-Saharan African countries are children and women around the time of childbirth, so achieving the health-related SDGs depends on blood and blood product availability to reduce maternal mortality, end preventable deaths of newborn babies and children younger than 5 years, and achieve universal health coverage. Blood shortages in sub-Saharan Africa can have devastating consequences. An estimated 70% of 287 000 pregnancy-associated deaths in the world in 2020 occurred in sub-Saharan African countries, predominantly due to obstetric haemorrhage. Insufficient blood supply for transfusion contributes substantially to such maternal deaths in hospitals in sub-Saharan Africa. 

Blood transfusions are also essential for managing sub-Saharan Africa's high rates of traffic accidents and childhood anaemia, which is commonly due to infections such as malaria, helminthiasis, and haemoglobinopathies. Sub-Saharan Africa is home to more than 75% of the 300 000–400 000 babies born each year globally with sickle cell disease; blood shortages contribute to 50–90% of these children dying before their fifth birthday. 

As health-care systems develop in sub-Saharan African countries, we can also expect increased blood needs for advanced cancer therapies, such as transplantation and cell therapy, organ transplant, dialysis, and cardiac surgeries.

The status of blood supply in sub-Saharan Africa: barriers and health impact - The Lancet

" ["post_title"]=> string(77) "The status of blood supply in sub-Saharan Africa: barriers and health impact." ["post_excerpt"]=> string(208) "Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs). " ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(7) "example" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-06-29 11:16:15" ["post_modified_gmt"]=> string(19) "2023-06-29 11:16:15" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(34) "https://test.hemoclear.com/?p=5005" ["menu_order"]=> int(2) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

The status of blood supply in sub-Saharan Africa: barriers and health impact.

Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).

 

Boost Autologuous bloodtransfusion Options
object(WP_Post)#10396 (24) { ["ID"]=> int(754) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2019-11-29 14:08:11" ["post_date_gmt"]=> string(19) "2019-11-29 14:08:11" ["post_content"]=> string(815) "

Important research quantifies the global scarcity of life-saving donor blood. As a result an estimated 10 million patients unnecessarily suffer or die annually . This is caused by a 30 million unit donor-blood shortage, preventing life-saving treatment by blood transfusion.

With good results, the World Health Organization has been stimulating voluntary blood donations. HemoClear contributes by unlocking the use of autologous blood for re-infusion. The easy to use HemoClear filter optimizes the blood quality in a cost-efficient way.

" ["post_title"]=> string(51) "The World Is Experiencing a Critical Blood Shortage" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(4) "open" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(54) "the-world-is-experiencing-a-critical-shortage-of-blood" ["to_ping"]=> string(0) "" ["pinged"]=> string(35) " https://test.hemoclear.com/product" ["post_modified"]=> string(19) "2023-06-19 13:07:25" ["post_modified_gmt"]=> string(19) "2023-06-19 13:07:25" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(33) "https://test.hemoclear.com/?p=754" ["menu_order"]=> int(3) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "1" ["filter"]=> string(3) "raw" }